Skip to main content
Clinical Trials/IRCT20190905044704N1
IRCT20190905044704N1
Not yet recruiting
Phase 3

The effect of intermediate dose of heparin solution in the prevention of central vein catheter occlusion on ICU admitted patients

Mashhad University of Medical Sciences0 sites150 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
150
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All ICU admitted patients who had 3 functional lumen catheter that insert less than 12 hours

Exclusion Criteria

  • Dialysis and phresis and pulmonary artery catheters and insertable ports
  • Age less than 18 y/o
  • Heparin sensivity and HIT
  • Coagolation system disorder and thrombocytopenia
  • Therapeutic dose of anticoagolant
  • Packed cell or any blood products transfusion
  • If the active lines needed more than 3 time hepparizination were excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials